Previous close | 0.0200 |
Open | 0.8300 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 270.00 |
Expiry date | 2024-05-17 |
Day's range | 0.0200 - 0.8300 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.